These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19935204)

  • 21. Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice.
    Nicoletti A; Kaveri S; Caligiuri G; Bariéty J; Hansson GK
    J Clin Invest; 1998 Sep; 102(5):910-8. PubMed ID: 9727059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice.
    Daugherty A; Puré E; Delfel-Butteiger D; Chen S; Leferovich J; Roselaar SE; Rader DJ
    J Clin Invest; 1997 Sep; 100(6):1575-80. PubMed ID: 9294126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
    Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunology. The push-me pull-you of T cell activation.
    Carson MJ; Lo D
    Science; 2001 Jul; 293(5530):618-9. PubMed ID: 11474091
    [No Abstract]   [Full Text] [Related]  

  • 25. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis.
    van Puijvelde GH; van Es T; van Wanrooij EJ; Habets KL; de Vos P; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2677-83. PubMed ID: 17901374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice.
    Liu SL; Li YH; Shi GY; Tang SH; Jiang SJ; Huang CW; Liu PY; Hong JS; Wu HL
    Cardiovasc Res; 2009 Apr; 82(1):161-9. PubMed ID: 19189960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice.
    Choi JH; Nam KH; Kim J; Baek MW; Park JE; Park HY; Kwon HJ; Kwon OS; Kim DY; Oh GT
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2404-9. PubMed ID: 16141407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atherogenesis on the chopping block.
    Gargalovic PS
    Cell Metab; 2009 May; 9(5):399-401. PubMed ID: 19416707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atherosclerosis: cell biology and lipoproteins.
    Wigren M; Björkbacka H
    Curr Opin Lipidol; 2010 Feb; 21(1):97-8. PubMed ID: 20101123
    [No Abstract]   [Full Text] [Related]  

  • 31. Total body proteoglycan 4 (Prg4) deficiency increases atherosclerosis susceptibility in apolipoprotein E knockout and low-density lipoprotein receptor knockout mice.
    Nahon JE; Hoekstra M; Van Eck M
    Atherosclerosis; 2018 Nov; 278():315-316. PubMed ID: 30477757
    [No Abstract]   [Full Text] [Related]  

  • 32. Apolipoprotein E knockout models.
    Kolovou G; Anagnostopoulou K; Mikhailidis DP; Cokkinos DV
    Curr Pharm Des; 2008; 14(4):338-51. PubMed ID: 18289060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transgenic animals in lipoprotein research.
    Aalto-Setälä K
    Ann Med; 1992 Oct; 24(5):405-9. PubMed ID: 1418927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atherosclerosis: cell biology and lipoproteins.
    Lu H; Daugherty A
    Curr Opin Lipidol; 2013 Feb; 24(1):107-8. PubMed ID: 23298967
    [No Abstract]   [Full Text] [Related]  

  • 35. Atherosclerosis: cell biology and lipoproteins.
    Lievens D; Gerdes N; Schober A; Weber C
    Curr Opin Lipidol; 2010 Jun; 21(3):284-5. PubMed ID: 20463476
    [No Abstract]   [Full Text] [Related]  

  • 36. [Knockout mouse].
    Gotoda T; Osuga J; Ishibashi S
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():626-9. PubMed ID: 11351662
    [No Abstract]   [Full Text] [Related]  

  • 37. The tale of the Watanabe rabbit.
    Lab Anim (NY); 2012 Oct; 41(10):277. PubMed ID: 22992501
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipoprotein and receptor interactions in vivo.
    Herz J; Willnow TE
    Curr Opin Lipidol; 1995 Apr; 6(2):97-103. PubMed ID: 7773575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No reduction of atherosclerosis in C-reactive protein (CRP)-deficient mice.
    Teupser D; Weber O; Rao TN; Sass K; Thiery J; Fehling HJ
    J Biol Chem; 2011 Feb; 286(8):6272-9. PubMed ID: 21149301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atherosclerosis: cell biology and lipoproteins.
    Bengtsson E; Björkbacka H
    Curr Opin Lipidol; 2016 Feb; 27(1):94-6. PubMed ID: 26655288
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.